Results 51 to 60 of about 73,957 (300)

Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In recent years, smaller‐volume radiotherapy has attracted attention. It appears to be a safe and effective treatment for glottic laryngeal cancer. This study evaluated the results of ultra‐hypofractionated radiotherapy for early glottic laryngeal cancer in unfit patients.
Mete Gundog, Esin Kiraz
wiley   +1 more source

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

open access: yesThoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source

Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children. [PDF]

open access: yes, 2020
OBJECTIVE:Brain arteriovenous malformations (AVMs) consist of dysplastic blood vessels with direct arteriovenous shunts that can hemorrhage spontaneously.
Abla, Adib A   +16 more
core   +1 more source

In vivo dose measurement using TLDs and MOSFET dosimeters for cardiac radiosurgery. [PDF]

open access: yes, 2012
In vivo measurements were made of the dose delivered to animal models in an effort to develop a method for treating cardiac arrhythmia using radiation. This treatment would replace RF energy (currently used to create cardiac scar) with ionizing radiation.
Blanck, Oliver   +6 more
core   +2 more sources

Current Landscape of Short‐T2 Imaging Techniques in the Musculoskeletal System: The Past, Present and Future

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Conventional MRI is limited in imaging tissues with short T2 relaxation times, such as bone, ligaments, and cartilage, due to their rapid signal decay. This limitation has spurred the development of specialized MRI techniques designed specifically for short‐T2 tissue imaging.
Pranjal Rai   +3 more
wiley   +1 more source

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation

open access: yesTechnology in Cancer Research & Treatment, 2020
Purpose: To investigate the role of intensity-modulated proton therapy (IMPT) for hepatocellular carcinoma (HCC) patients to be treated with stereotactic body radiation therapy (SBRT) in a risk-adapted dose prescription regimen.
Luca Cozzi PhD   +9 more
doaj   +1 more source

Brain Tumor Characterization Using Multiple MR Parameters From Multi‐Contrast EPI With Keyhole (GE‐SE EPIK) Including Oxygen Extraction Fraction: A Comparison to O‐(2‐[18F]Fluoroethyl)‐L‐Tyrosine (FET) Positron Emission Tomography

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Tumor characterization and treatment efficacy are associated with tissue hypoxia. MR‐derived oxygen extraction fraction (OEF) may offer valuable tumor insights but depends on multiple measurement parameters, often requiring multiple sequence acquisitions.
Fabian Küppers   +10 more
wiley   +1 more source

The use of cannabis as an antiepileptic treatment in Mexico: A review, bioethical analysis, discussion and position of the Hospital General de México Epilepsy Clinic

open access: yesRevista Médica del Hospital General de México, 2016
In Mexico and the United States of America (USA), a debate was recently opened on the use of some cannabis extracts as anticonvulsive drugs. Given the broad influence that social networks and the media have on the general population, it is worth ...
M. Kalkach-Aparicio   +9 more
doaj   +1 more source

Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors. [PDF]

open access: yes, 2013
Glioblastoma multiforme (GBM) is the most common primary brain cancer. Even with aggressive combination therapy, the median life expectancy for patients with GBM remains approximately 14 months.
Jackson, Christopher   +5 more
core   +1 more source

Hypofractionation Utilisation in Radiation Therapy: A Regional Department Evaluation

open access: yesJournal of Medical Radiation Sciences, EarlyView.
This study has validated the increase of hypo fractionated treatments over a range of cancer sites and treatment intents, with increased treatment complexity over a decade (2012, 2019, 2022). This has a direct impact on both the departmental resources and patient‐centred care, offering value‐based radiotherapy.
Cyrena Tabet   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy